133099-79-3 Usage
General Description
H-D-Ser-Obzl Hydrochloride salt is a chemical compound that incorporates the amino acid serine, hydrochloride salt, and an obzl group. Serine is a non-essential amino acid involved in various biological processes, including protein synthesis and neurotransmitter production. The addition of the hydrochloride salt to the compound increases its solubility in water, making it easier to work with in laboratory settings. The obzl group attached to the serine molecule may confer specific chemical properties or functions, depending on the intended application. Overall, H-D-Ser-Obzl Hydrochloride salt is a versatile chemical compound with potential uses in research, pharmaceutical development, and other fields.
Check Digit Verification of cas no
The CAS Registry Mumber 133099-79-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,3,0,9 and 9 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 133099-79:
(8*1)+(7*3)+(6*3)+(5*0)+(4*9)+(3*9)+(2*7)+(1*9)=133
133 % 10 = 3
So 133099-79-3 is a valid CAS Registry Number.
133099-79-3Relevant articles and documents
Stereoselective synthesis of natural and non-natural thomsen-nouveau antigens and hydrazide derivatives
Shaik, Ahmad Ali,Nishat, Sharmeen,Andreana, Peter R.
, p. 2582 - 2585 (2015/06/16)
A selective glycosylation strategy enabling access to all stereochemical combinations of tumor associated Thomsen-nouveau (Tn) antigen, d-GalNAc-O-Ser/Thr, has been developed. The key component for selectivity is the phthalimide-protected d- or l-amino acid acceptors which allow access to α- or β-anomers in excellent yields (72-96%) and selectivity (~100%) when appropriate C-2 substitution is installed. The glycoamino acid intermediates were divergently converted to Tn-based carboxylates or to hydrazides by tandem Pd-C debenzylation followed by treatment with hydrazine hydrate or hydrazine hydrate treatment alone.